PF-3758309 5mg 5mg | Purity Not Available
Adooq Bioscience
PF-3758309 is a small-molecule p21-activated kinase inhibitor inhibiting oncogenic signaling and tumor growth.
More Information Supplier PagePF-3758309 is a small-molecule p21-activated kinase inhibitor inhibiting oncogenic signaling and tumor growth.
More Information Supplier PagePF-3758309 is a small-molecule p21-activated kinase inhibitor inhibiting oncogenic signaling and tumor growth.
More Information Supplier PagePF-3758309 is a small-molecule p21-activated kinase inhibitor inhibiting oncogenic signaling and tumor growth.
More Information Supplier PagePF-04554878 is a novel FAK kinase inhibitor that decreases growth and induces apoptosis in pancreatic neuroendocrine tumor cells
More Information Supplier PagePF-04554878 is a novel FAK kinase inhibitor that decreases growth and induces apoptosis in pancreatic neuroendocrine tumor cells
More Information Supplier PagePF-04554878 is a novel FAK kinase inhibitor that decreases growth and induces apoptosis in pancreatic neuroendocrine tumor cells
More Information Supplier PagePF-04554878 is a novel FAK kinase inhibitor that decreases growth and induces apoptosis in pancreatic neuroendocrine tumor cells
More Information Supplier PageRetigabine is an anticonvulsant used as a treatment for partial epilepsies.
More Information Supplier PageRetigabine is an anticonvulsant used as a treatment for partial epilepsies.
More Information Supplier PageRetigabine is an anticonvulsant used as a treatment for partial epilepsies.
More Information Supplier Page